Microfluidics-Based Point-of-Care Testing (POCT) Devices in Dealing with Waves of COVID-19 Pandemic: The Emerging Solution
- 27 April 2022
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 5 (5), 2046-2068
- https://doi.org/10.1021/acsabm.1c01320
Abstract
Recent advances in microfluidics-based point-of-care testing (POCT) technology such as paper, array, and beads have shown promising results for diagnosing various infectious diseases. The fast and timely detection of viral infection has proven to be a critical step for deciding the therapeutic outcome in the current COVID-19 pandemic, which in turn not only enhances the patient survival rate but also reduces the disease-associated comorbidities. In the present scenario, rapid, noninvasive detection of the virus using low cost and high throughput microfluidics-based POCT devices embraces the advantages over existing diagnostic technologies, for which a centralized lab facility, expensive instruments, sample pretreatment, and skilled personnel are required. Microfluidic-based multiplexed POCT devices can be a boon for dinical diagnosis in developing countries that lacks a centralized health care system and resources. The microfluidic devices can be used for disease diagnosis and exploited for the development and testing of drug efficacy for disease treatment in model systems. The havoc created by the second wave of COVID-19 led several countries' governments to the back front. The lack of diagnostic kits, medical devices, and human resources created a huge demand for a technology that can be remotely operated with single touch and data that can be analyzed on a phone. Recent advancements in information technology and the use of smartphones led to a paradigm shift in the development of diagnostic devices, which can be explored to deal with the current pandemic situation. This review sheds light on various approaches for the development of cost-effective microfluidics POCT devices. The successfully used microfluidic devices for COVID-19 detection under clinical settings along with their pros and cons have been discussed here. Further, the integration of microfluidic devices with smartphones and wireless network systems using the Internet-of-things will enable readers for manufacturing advanced POCT devices for remote disease management in low resource settings.Keywords
This publication has 195 references indexed in Scilit:
- Disposable electrochemical sensors: A mini reviewElectrochemistry Communications, 2014
- Optimization of laser machining process for the preparation of photomasks, and its application to microsystems fabricationJournal of Micro/Nanolithography, MEMS, and MOEMS, 2013
- Austerity: a failed experiment on the people of EuropeClinical Medicine, 2012
- Prevalence and predictors of posttraumatic stress symptoms in utility workers deployed to the World Trade Center following the attacks of September 11, 2001Depression and Anxiety, 2010
- Comprehensive Detection and Identification of Seven Animal Coronaviruses and Human Respiratory Coronavirus 229E with a Microarray Hybridization AssayIntervirology, 2009
- Emergency Preparedness and Public Health Systems: Lessons for Developing CountriesAmerican Journal of Preventive Medicine, 2008
- Risk and resilience in canine search and rescue handlers after 9/11Journal of Traumatic Stress, 2005
- SARS Control and Psychological Effects of Quarantine, Toronto, CanadaEmerging Infectious Diseases, 2004
- Development and Evaluation of a Novel Loop-Mediated Isothermal Amplification Method for Rapid Detection of Severe Acute Respiratory Syndrome CoronavirusJournal of Clinical Microbiology, 2004
- Loop-mediated isothermal amplification of DNANucleic Acids Research, 2000